The American Heart Association and American Stroke Association published updated guidelines for recurrent stroke prevention online Oct. 21,2010 in the journal Stroke. The last update to the AHA/ASA was in 2006, but results from several studies testing different interventions contributed to the need for the new report. “We need to reevaluate the science every few years to optimize prevention,” stated Dr. Karen L. Furie, chair of the 18-member writing committee and director of the stroke service at Massachusetts General Hospital, Boston, MA in a statement accompanying the updated guidelines.
New recommendations in the guidelines cover control of risk factors, interventions for atherosclerotic disease, antithrombotic therapies for cardioembolism, and use of antiplatelet drugs for noncardioembolic stroke.
What did the new guidelines have to say about patent foramen ovale (PFO)?
According to the report, “evidence is also insufficient to establish whether anticoagulation therapy is better than aspirin therapy for secondary stroke prevention in patients who have a patent foramen ovale.”
The full report can be accessed at the American Heart Association and American Stroke Association website.
update by David Dansereau for know-stroke.org
New AHA/ASA Recurrent Stroke Prevention Guidelines Released